Head-to-head comparison
Breeze Meds vs Hims & Hers
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Charges nothing until a provider approves you, and now prints a starting price per product on its home page — $199 semaglutide, $399 tirzepatide — for the lowest dose.
From $199/mo sema · From $399/mo tirz · Verified August 2026
Marked down on: The public cards print only a floor per product — "Starting at $199" semaglutide, "Starting at $399" tirzepatide — and no term or dose ladder behind it
Desk Score
Mass-market app-first program with nationwide polish — tirzepatide pricing disclosure lags the ranking.
$199/mo sema
Marked down on: Tirzepatide pricing inconsistently disclosed
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Hims & Hers takes this head-to-head with the higher Desk Score, 79/100 (C+) against 78/100 (C+) for Breeze Meds. Breeze Meds still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Breeze Meds
78/100
C+
Hims & Hers
79/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Breeze Meds | Hims & Hers |
|---|---|---|
| Semaglutide | From $199/moFrom $199/mo (lowest dose — the card reads "Starting at $199"; higher doses may cost more; compounded injectable) | $199/mo$199/mo |
| Tirzepatide | From $399/moFrom $399/mo (lowest dose — the card reads "Starting at $399"; higher doses may cost more; the $299 first-month rate seen inside the intake in July is no longer shown anywhere; compounded injectable) | Not listed on Hims & Hers's site |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | People who want an all-in nationwide option and accept that the published figures are lowest-dose floors, with the exact plan price inside the intake. | People who want a familiar consumer-brand app experience and don't need tirzepatide. |
| Desk Score | 78/100C+ | 79/100C+ |
The verdict
Desk pick — Hims & HersHims & Hers takes this head-to-head with the higher Desk Score, 79/100 (C+) against 78/100 (C+) for Breeze Meds. Breeze Meds still holds its ground where its strengths line up with yours.
Choose Breeze Meds if…
People who want an all-in nationwide option and accept that the published figures are lowest-dose floors, with the exact plan price inside the intake.
From $199/mo sema · From $399/mo tirz · All 50 states
Choose Hims & Hers if…
People who want a familiar consumer-brand app experience and don't need tirzepatide.
$199/mo sema · All 50 states
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Breeze Meds · Hims & Hers.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Breeze Meds vs CoreAge Rx
- CoreAge Rx vs Hims & Hers
- Breeze Meds vs HealthRX
- Hims & Hers vs Ondra Health
- Breeze Meds vs RestorLife Med
- Hims & Hers vs Vaylen
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.